Drugs

, Volume 45, Supplement 3, pp 114–118 | Cite as

Quinolones in the Treatment of Acute Bacterial Diarrhoeal Diseases

  • H. Erdal Akalin
State-of-The-Art Presentations

Summary

Acute bacterial diarrhoea is still an important disease, especially in developing countries. Resistance to antibiotics among enteric pathogens is relatively common in many parts of the world. The quinolones are active in vitro against these organisms, and achieve high stool concentrations. Because of these features, quinolones have been used in the treatment of acute diarrhoeal diseases caused by various bacteria. They appear to be effective in the therapy of shigellosis and travellers’ diarrhoea, as well as in the prevention of diarrhoeal disease in travellers. However, their role in the treatment of salmonella gastroenteritis has not been established yet.

Keywords

Ofloxacin Quinolones Norfloxacin Enteric Pathogen Shigellosis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahmad F, Bray G, Prescott RWG, Aquilla S, Lightfoot NF. Use of ciprofloxacin to control a salmonella outbreak in a long-stay psychiatric hospital. Journal of Hospital Infection 17: 171–178, 1991PubMedCrossRefGoogle Scholar
  2. Akalin HE. Antibiotic treatment of acute bacterial diarrheas: the role of new quinolones. Therapy of Infectious Diseases 6: 205–213, 1991Google Scholar
  3. Akalin HE, Baykal M, Berkman E. In vitro activity of quinolones against multiply-resistant Salmonella species. In Berkarda & Kummerle (Eds) Progress in antimicrobial and anticancer chemotherapy, Vol. 2, pp. 1965–1967, Ecomed, Munich, 1987Google Scholar
  4. Akalin HE, Firat M, Onal S, Serin A, Baykal M. Clinical efficacy of single-dose or one-day treatment with ofloxacin in shigellosis. Reviews of Infectious Diseases 11 (Suppl. 5): S1152–S1153, 1989Google Scholar
  5. Aserkoff B, Bennett JV. Effect of antibiotic therapy in acute salmonellosis on the fecal excretion of salmonellae. New England Journal of Medicine 281: 636–640, 1969PubMedCrossRefGoogle Scholar
  6. Ashkenazi S, Cleary TG. Antibiotic treatment of bacterial gastroenteritis. Pediatric Infectious Disease Journal 10: 140–148, 1991PubMedCrossRefGoogle Scholar
  7. Bennish ML, Salam MA, Khan WA, Khan AM. Treatment of shigellosis: III. Comparison of one- or two dose ciprofloxacin with standard 5-day therapy. Annals of Internal Medicine 117: 727–734, 1992PubMedGoogle Scholar
  8. Black RE. Pathogens that cause travellers’ diarrhea in Latin America and Africa. Reviews of Infectious Diseases 8 (Suppl. 2): S131–S135, 1986PubMedCrossRefGoogle Scholar
  9. Butler T, Lolekha S, Rasidi C, Kadio A, Leal Del Rosal P, et al. Treatment of acute bacterial diarrhea: results of a multicenter international trial comparing placebo with fleroxacin given as a single dose or once-daily for 3 days. 17th International Congress of Chemotherapy, Berlin, June 23–28, 1991. Abstract no. 1456, 1991Google Scholar
  10. Carlson JR, Thornton SA, DuPont HL, West AH, Mathewson JJ. Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens. Antimicrobial Agents and Chemotherapy 24: 509–513, 1983PubMedCrossRefGoogle Scholar
  11. Carlstedt G, Dahl P, Niklasson PM, Gullberg K, Banck G, et al. Norfloxacin treatment of salmonellosis does not shorten the carrier stage. Scandinavian Journal of Infectious Diseases 22: 553–556, 1990PubMedCrossRefGoogle Scholar
  12. Chatkaeomoratkot A, Echeverria P, Taylor DN, Seriwata J, Leksombo U, et al. Trimethoprim-resistant Shigella and enterotoxigenic Escherichia coli strains in children in Thailand. Pediatric Infectious Disease Journal 6: 735–739, 1987CrossRefGoogle Scholar
  13. Cofsky RD, du Bouhet L, Landesman SH. Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers. Antimicrobial Agents and Chemotherapy 26: 110–111, 1984PubMedCrossRefGoogle Scholar
  14. De Mol P, Mets T, Lagasse R, Vandepitte J, Mutwewingabo A, et al. Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid. Journal of Antimicrobial Chemotherapy 19: 695–698, 1987PubMedCrossRefGoogle Scholar
  15. DuPont HL. Use of quinolones in the treatment of gastrointestinal infections. European Journal of Clinical Microbiology and Infectious Diseases 10: 325–329, 1991aCrossRefGoogle Scholar
  16. DuPont HL. Chemoprophylaxis remains an option in travellers’ diarrhea. American Journal of Gastroenterology 86: 402–404, 1991bGoogle Scholar
  17. DuPont HL, Carrado ML, Sabbaj J. Use of norfloxacin in the treatment of gastrointestinal infections. American Journal of Medicine 82 (Suppl. 6B): 79–83, 1987PubMedCrossRefGoogle Scholar
  18. DuPont HL, Ericsson CD, Reves RR, Galindo E. Antimicrobial therapy for travellers’ diarrhea. Reviews of Infectious Diseases 8 (Suppl. 2): S217–S222, 1986PubMedCrossRefGoogle Scholar
  19. Edlund C, Bergan T, Josefsson K, Solbert R, Nord CE. Effect of norfloxacin on human oropharyngeal and colonie microflora and multi-dose pharmacokinetics. Scandinavian Journal of Infectious Diseases 19: 113–121, 1987PubMedCrossRefGoogle Scholar
  20. Eng RHK, Smith SM, Lo W, Lowe WC. Eradication of non-typhi salmonella colonization by ciprofloxacin: implications for health care workers and institutionalized patients. American Journal of Medicine 89: 386–388, 1990PubMedCrossRefGoogle Scholar
  21. Ericsson CD, Johnson PC, DuPont HL, Morgan DR, Bitsura JA, et al. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travellers’ diarrhea. Annals of Internal Medicine 106: 216–220, 1987PubMedGoogle Scholar
  22. Firat M, Akalin HE, Serin A, Baykal M. In vitro activity and efficacy of ofloxacin in shigellosis due to multiply-resistant strains. In Berkarda & Kummerle (Eds) Progress in antimicrobial and anticancer chemotherapy, Vol. 2, pp. 1780–1782, Ecomed, Munich, 1987Google Scholar
  23. Goodman LJ, Fliegelman RM, Trenholme GM, Kaplan RL. Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens. Antimicrobial Agents and Chemotherapy 25: 504–506, 1984Google Scholar
  24. Goodman LJ, Trenholme GM, Kaplan RL, Segreti J, Hines D, et al. Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Archives of Internal Medicine 150: 541–546, 1990PubMedCrossRefGoogle Scholar
  25. Gootz TD, Martin BA. Characterization of high-level quinolone resistance in Campylobacter jejuni. Antimicrobial Agents and Chemotherapy 35: 840–845, 1991PubMedCrossRefGoogle Scholar
  26. Gorbach SL, Edelman R (Eds) Travellers’ diarrhea: National Institutes of Health Consensus Development Conference, Consensus Development Conference Statement. Reviews of Infectious Diseases 8 (Suppl. 2); S227–S233, 1986Google Scholar
  27. Gotuzzo E, Oberhelman RA, Maguina C, Berry SJ, Yi A, et al. Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults. Antimicrobial Agents and Chemotherapy 33: 1101–1104, 1989PubMedCrossRefGoogle Scholar
  28. Guerrant RL, Hughes JM, Lima NL, Crane J. Diarrhea in developed and developing countries: magnitude, special settings, and etiologies. Reviews of Infectious Diseases 12 (Suppl. 1): S41–S50, 1990PubMedCrossRefGoogle Scholar
  29. Gür D, Hasçelik G, Akyün Y, Akalin HE. In vitro activity of quinolones against Campylobacter spp., trimethoprim-sulfamethoxazole resistant Salmonella spp., and Shigella spp. 16th International Congress of Chemotherapy, Jerusalem, Israel, June 1989. pp. 505-1-505–2, 1989Google Scholar
  30. Halpern Z, Averbuch M, Dan M, Giladi M, Levo Y. The differential leukocyte count in adults with acute gastroenteritis. Scandinavian Journal of Infectious Diseases 24: 205–207, 1992PubMedCrossRefGoogle Scholar
  31. Harnett N, McLeod S, AuYoung Y, Krishnan C. Increasing incidence of resistance among shigellae to trimethoprim. Lancet 337: 622, 1991PubMedCrossRefGoogle Scholar
  32. Heikkila E, Siitonen A, Jahkola M, Fling M, Sundstrüm L, et al. Increase of trimethoprim resistance among Shigella species 1975–1988: analysis of resistance mechanisms. Journal of Infectious Diseases 161: 1242–1248, 1990PubMedCrossRefGoogle Scholar
  33. Howard AJ, Joseph TD, Bloodworth LLO, Frost JA, Chart H, et al. The emergence of ciprofloxacin resistance in Salmonella typhimurium. Journal of Antimicrobial Chemotherapy 26: 296–298, 1990PubMedCrossRefGoogle Scholar
  34. Hyams KC, Bourgeois AL, Merrel BR, Rozmajzi P, Escamilla J, et al. Diarrheal disease during Operation Desert Shield. New England Journal of Medicine 325: 1423–1428, 1991PubMedCrossRefGoogle Scholar
  35. Johnson PC, Ericsson CD, Morgan DR, DuPont HL, Cabada FJ. Lack of emergence of resistant fecal flora during successful prophylaxis of travellers’ diarrhea with norfloxacin. Antimicrobial Agents and Chemotherapy 30: 671–674, 1986PubMedCrossRefGoogle Scholar
  36. Kazemi M, Gumbert TG, Marks MI. A controlled trial comparing sulfamethoxazole-trimethoprim, ampicillin, and no therapy in the treatment of salmonella gastroenteritis in children. Journal of Pediatrics 83: 646–650, 1973PubMedCrossRefGoogle Scholar
  37. Lang R, Lishner M, Segev S, Rubinstein E. Ofloxacin and the gastrointestinal tract: a potential role in the treatment of bacterial enteritis. Journal of Antimicrobial Chemotherapy 26 (Suppl. D): 45–53, 1990PubMedGoogle Scholar
  38. Loltekha S, Vibulbandhitkit S, Poonyarit P. Response to antimicrobial therapy for shigellosis in Thailand. Reviews of Infectious Diseases 13 (Suppl. 4): S342–S346, 1991CrossRefGoogle Scholar
  39. Lopez-Brea M, Jimenez ML, Lopez Lavid MC, Padilla B, Isasia T. Norfloxacin vs trimethoprim-sulfamethoxazole in the treatment of salmonella gastroenteritis. Reviews of Infectious Diseases 11 (Suppl. 5): S1153–S1154, 1989Google Scholar
  40. Murray BE. Resistance of Shigella, Salmonella, and other selected enteric pathogens to antimicrobial agents. Reviews of Infectious Diseases 8 (Suppl. 2): S172–S181, 1986PubMedCrossRefGoogle Scholar
  41. Murray BE. Quinolones and gastrointestinal tract. European Journal of Clinical Microbiology and Infectious Diseases 8: 1093–1101, 1989CrossRefGoogle Scholar
  42. Neill MA, Opal SM, Heelan J, Giusti R, Cassidy JE, et al. Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during an outbreak in health care workers. Annals of Internal Medicine 114: 195–199, 1991PubMedGoogle Scholar
  43. Nelson JD, Kusmiesz H, Jackson LH, Woodman E. Treatment of Salmonella gastroenteritis with ampicillin, amoxicillin, or placebo. Pediatrics 65: 1125–1130, 1980PubMedGoogle Scholar
  44. Neu HC. Clinical use of the quinolones. Lancet 2: 1319–1322, 1987PubMedCrossRefGoogle Scholar
  45. O’Hare MD, Felmingham D, Ridgway GL, Grunebert RN. The comparative in vitro activity of twelve 4-quinolone antimi-crobials against enteric pathogens. Drugs and Experimental Clinical Research 11: 253–257, 1985Google Scholar
  46. Piddock LJV, Whale K, Wise R. Quinolone resistance in salmonella: clinical experience. Lancet 335: 1459, 1980CrossRefGoogle Scholar
  47. Pichler HET, Diridl G, Stickler K, Wolf D. Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea. American Journal of Medicine 82 (Suppl. 4A): 329–332, 1987PubMedGoogle Scholar
  48. Rademaker CMA, Hoepelman IM, Wolfhagen MJHM, Beumer H, Rozenberg-Arska M, et al. Results of a double-blind placebo controlled study using ciprofloxacin for prevention of travellers’ diarrhea. European Journal of Clinical Microbiology and Infectious Diseases 8: 690–694, 1989CrossRefGoogle Scholar
  49. Rogerie F, Ott D, Vandepitte J, Verbist L, Lemmens P, et al. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults. Antimicrobial Agents and Chemotherapy 29: 883–886, 1986PubMedCrossRefGoogle Scholar
  50. Rosenthal SL. Exacerbation of Salmonella enteritis due to ampicillin. New England Journal of Medicine 28: 147–148, 1969CrossRefGoogle Scholar
  51. Scott DA, Haberberger RL, Thornton SA, Hyams KG. Norfloxacin for prophylaxis of travellers’ diarrhea in U.S. military personnel. American Journal of Tropical Medicine and Hygiene 42: 160–164, 1990Google Scholar
  52. Snyder JD, Merson MH. The magnitude of the global problem of acute diarrheal disease: a review of active surveillance. Bulletin of World Health Organization 60: 605–613, 1982Google Scholar
  53. Steffen R, Jori R, DuPont HL, Mathewson JJ, Murray BE, et al. Fleroxacin, a long-acting fluoroquinolone, as effective therapy for travellers’ diarrhea. Reviews of Infectious Diseases 11 (Suppl. 5): S1154–1155, 1989Google Scholar
  54. Taylor DN, Echeverria P. Etiology and epidemiology of travellers’ diarrhea in Asia. Reviews of Infectious Diseases 8 (Suppl. 2): S136–S141, 1986PubMedCrossRefGoogle Scholar
  55. Tigaud S, Lucht F, Peyramond D, Noel F. Use of ofloxacin for the treatment of enteric infections. Reviews of Infectious Diseases 10 (Suppl. 1): S207, 1988Google Scholar
  56. Waldvogel FA. Clinical role of the quinolones today and in the future. European Journal of Clinical Microbiology and Infectious Diseases 8: 1075–1079, 1989CrossRefGoogle Scholar
  57. Walsh JA, Warren KJ. Selective primary care: an interim strategy for disease control in developing countries. New England Journal of Medicine 301: 967–974, 1979PubMedCrossRefGoogle Scholar
  58. Williams HMS, Richards J. Single-dose ciprofloxacin for shigellosis. Lancet 335: 1343–1344, 1990PubMedCrossRefGoogle Scholar
  59. Willocks LJ, Thompson C, Emmanuel FXS, Bligh J, Jones ME, et al. Hospital outbreak of Salmonella enteritidis infections treated with ciprofloxacin. Lancet 335: 1404–1405, 1990PubMedCrossRefGoogle Scholar
  60. Wistrüm J, Norrby SR. Antibiotic prophylaxis of travellers’ diarrhoea. Scandinavian Journal of Infectious Diseases (Suppl. 70): 111–129,1990Google Scholar
  61. Wistrüm J, Norrby SR, Burman LG, Lundholm R, Jellheden B, et al. Norfloxacin versus placebo for prophylaxis against travellers’ diarrhoea. Journal of Antimicrobial Chemotherapy 20: 563–574, 1987CrossRefGoogle Scholar
  62. Wistrüm J, Jertborn M, Ekwall E, Norlin K, Süderquist B, et al. Empiric treatment of acute diarrheal disease with norfloxacin. Annals of Internal Medicine 117: 202–208, 1992Google Scholar

Copyright information

© ADIS International Limited 1993

Authors and Affiliations

  • H. Erdal Akalin
    • 1
  1. 1.Department of Medicine, Section of Infectious DiseasesHacettepe University School of MedicineAnkaraTurkey

Personalised recommendations